Stocks
Heron Therapeutics (HRTX) ROE US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | -50.7% | -94.9% | -280.6% | -991.1% | 325.4% | 69.9% | |
| Changes by years, y/y, % | -2pp | -44pp | -186pp | -711pp | +1 317pp | |||
Heron Therapeutics. ROE, %
Heron Therapeutics. ROE, changes, pp
Heron Therapeutics (HRTX) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 456.2% | 324.6% | 239.7% | 126.9% | 69.9% | 69.9% | |
| Changes by years, y/y, % | +1 446pp | +1 778pp | -1 203pp | -239pp | -386pp | |||
| Changes by quarters, q/q, % | +90pp | -132pp | -85pp | -113pp | -57pp | |||
